mTORC1-driven Accumulation of the Oncometabolite Fumarate as a Potential Critical Step in Renal Cancer Progression

Molecular and Cellular Oncology - United Kingdom
doi 10.1080/23723556.2018.1537709
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Homocysteine Is an Oncometabolite in Breast Cancer, Which Promotes Tumor Progression and Metastasis

2014English

Angiogenic Switches Play a Critical Progression in Cancer

Journal of Angiotherapy
2018English

Role of the Exosome in Ovarian Cancer Progression and Its Potential as a Therapeutic Target

Cancers
Cancer ResearchOncology
2019English

A Biomimetic 3D Model of Hypoxia-Driven Cancer Progression

Scientific Reports
Multidisciplinary
2019English

Kynurenine: An Oncometabolite in Colon Cancer

Cell Stress
2020English

mTORC1 as a Regulator of Mitochondrial Functions and a Therapeutic Target in Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

Chromatin Remodeling Factor LSH Affects Fumarate Hydratase as a Cancer Driver

Chinese Journal of Cancer
2016English

The ShcA Adaptor Protein Is a Critical Regulator of Breast Cancer Progression

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2008English

Loss of ER Expression as a Common Step in Estrogen-Dependent Tumor Progression

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy